Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Blue Apron

Beyond Meat

Johnson & Johnson

Rite Aid

Shopify

Spotify

These stocks to sell will likely face pain in 2020 as these equities face worsening conditions and increasing financial and market pressure.

7 Unsteady Stocks Investors Should Consider Selling Before 2020

Trulieve Cannabis Corp.

Canopy Growth

Canopy, Tilray, And Trulieve: Three Cannabis Companies - But Only One Is A Buy, Two Are Holds

Tilray Inc (NASDAQ: TLRY) is focused on brands, distribution, strategic partners and an asset-light model, according to Cantor Fitzgerald.

Tilray Analyst's Conversation With CFO Builds Faith In Positive Catalysts

Hope for U.S. legalization helped Tilray stock, but financial conditions indicate it may struggle to remain top-tier or perhaps, survive.

Investors Should Stop Calling Tilray Stock a Top-Tier Marijuana Name

Tilray (TLRY) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Tilray (TLRY) Looks Good: Stock Adds 7.2% in Session

Despite the steep discount in Tilray stock, this remains a name to avoid because neither the fundamentals nor technicals imply a positive trajectory.
The post Don’t Buy Tilray Stock Despite the Cannabis Rebound appeared first on InvestorPlace.

Don’t Buy Tilray Stock Despite the Cannabis Rebound

Aurora Cannabis

Aphria

Cronos Group

The landmark legislation could pave the way for weed to become legal at the federal level.

Cannabis Stocks Soar as Bill to Legalize Marijuana Approved

Shares of marijuana companies rose on Thursday after a U.S. congressional committee passed a legislation to decriminalize cannabis, taking it a step closer to being approved by the Democratic-controlled House of Representatives.

Pot stocks soar as U.S. House committee clears bill on federal weed legalization

Tilray stock is a minefield of risk. "Cannabis 2.0" could improve their fortunes.

Don’t Bet on Tilray Stock Surviving the Cannabisphere Meltdown

OrganiGram Holdings Inc.

One retail cannabis store for every 600,000 residents simply isn't enough in Canada's heaviest-populated province.

Blame It on Ontario: Why 1 Province Is the Main Culprit Behind the Canadian Cannabis Industry's Woes

CannTrust Holdings

HEXO Corp

Marijuana stocks have been gutted this year. But a new survey finds that believers still exist — even if fewer of them make money on the industry.

Marijuana Stocks Are Flailing, But Survey Finds Believers Hang On

Could its latest earnings report signal the start of a comeback for Tilray?

Is Tilray Ready to Bounce Back?

Another disappointing quarter threatens to send the struggling stock even further down in price.

4 Concerning Numbers From Tilray's Q3 Results

China Mobile Limited

SmileDirectClub

An overseas telco giant, former marijuana highflier, and dental products IPO are hitting fresh 52-week lows.

3 Surprising Stocks Hitting New Lows Last Week: CHL, SDC & TLRY

Tilray’s acquisition of Manitoba Harvest should help Tilray stock. TLRY stock may perform better than other marijuana stocks.

The Manitoba Harvest Acquisition Saved Tilray Stock This Quarter

The most popular cannabis stocks on the planet just proved that the grass isn't getting greener -- at least not yet.

Earnings Roundup: Aurora, Canopy, Cronos, and Tilray Report Their Quarterly Results

Curaleaf Holdings, Inc.

Greenlane Holdings

Akerna Corp

Amplify Alternative Harvest ETF

SNDL Inc.

Are marijuana stocks on U.S. exchanges a good buy now?

Are These Marijuana Stocks A Good Buy Now? Look Past The Hype

Marijuana stocks were on a tear last year, but 2019 has sent stock tumbling back down to Earth. What happened?

Why Marijuana Stocks Plummeted in 2019

Tilray stock, along with the rest of the marijuana sector, have fallen out of favor and won't get back up. They need consistent profit.

Tilray Stock Has Fallen and Can’t Get Up

Tilray Inc. shares TLRY, -1.60% fell 3.2% in premarket trade Wednesday, as analysts weighed in on a mixed set of earnings with Benchmark analyst Mike Hickey slashing his price target in half.

Tilray stock slides premarket as analysts weigh in on disappointing earnings

The Canadian cannabis producer generated strong overall revenue growth. But don't overlook several key areas of concern.

3 Glaring Problems in Tilray's Q3 Results

Tilray, Inc. (TLRY) CEO Brendan Kennedy on Q3 2019 Results - Earnings Call Transcript

The company's revenue beats expectations, but its net loss is deeper than analysts anticipated.

Tilray Sales Blast Higher in Mixed Q3

"One could argue this vaping crisis could lead to more legalization," Tilray CEO Brendan Kennedy tells CNBC.

Vaping illness outbreak could lead to marijuana legalization, Tilray CEO says

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -72.41% and 3.05%, respectively, for the quarter ended September 2019.

News for Tilray Brands Stock (TLRY)